Bristol-Myers Squibb

Vertex and Alnylam orphan drugs set for EU approval

https://pharmaphorum.com/market-access-2/chmp-vertex-symkevi-alnylam-onpattro/

Pfizer backed off, but the price hike game continues

https://pharmaphorum.com/news/pfizer-backed-off-but-the-price-hike-game-continues/

BMS makes record $1.8bn bet on Nektar cancer drug

https://pharmaphorum.com/news/bms-makes-record-1-8bn-bet-on-nektar-cancer-drug/

Clovis and BMS combine cancer drugs in late-stage trials

https://pharmaphorum.com/news/clovis-bms-cancer/

Soriot commits to AstraZeneca as shares slide

https://pharmaphorum.com/news/soriot-commits-astrazeneca-shares-slide/

BMS appoints new science chief in fall-out from Opdivo setback

https://pharmaphorum.com/news/bms-appoints-new-science-chief-fall-opdivo-setback/

Is BMS the next pharma takeover target?

https://pharmaphorum.com/news/bms-next-pharma-takeover-target/

Innate and BMS’ immunotherapy fails in phase 2 trial

https://pharmaphorum.com/news/innates-immunotherapy-fails-phase-2-aml-trial/

BMS suffers further setback in lung cancer

https://pharmaphorum.com/news/bms-faces-setback-lung-cancer/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search